Drug: TAXOL Injury: General physical health deterioration Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 126541302 | TAXOL | General physical health deterioration | ROCHE | 26.00 YR | F | 0 | 20160819 | GB |
| 126647462 | TAXOL | General physical health deterioration | NOVARTIS | 26.00 YR | F | 0 | 20160824 | GB |
| 126820471 | TAXOL | General physical health deterioration | FRESENIUS KABI | 0.00 | F | 0 | 20160824 | GB |
| 126866231 | TAXOL | General physical health deterioration | MYLAN | 0.00 | 0 | 20160825 | GB | |
| 127016942 | TAXOL | General physical health deterioration | ACCORD | 26.00 YR | F | 0 | 20160902 | GB |
| 127716301 | TAXOL | General physical health deterioration | AMGEN | 0.00 | 0 | 20160922 | US |
Total Records: 6 Number of Pages: 1